The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract

Journal of Assisted Reproduction and Genetics

Volumn 27, Issue 6, 2010, Pages 327-333

  Verpoest, Willem ^a   Seneca, Sara ^b   De Rademaeker, Marjan ^b   Sermon, Karen ^b   De Rycke, Martine ^b   De Vos, Michel ^a   Haentjens, Patrick ^b   Devroey, Paul ^a   Liebaers, Ingeborg ^b  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

ICSI; Myotonic dystrophy; PGD; Repeats; Reproductive outcome

Indexed keywords

DNA FRAGMENT; FOLLITROPIN;

ADULT; ARTICLE; BIVARIATE ANALYSIS; BLASTOMERE; BODY MASS; CATARACT; CORRELATIONAL STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GROUPS BY AGE; GROWTH RETARDATION; HUMAN; HYDRAMNIOS; INTRACYTOPLASMIC SPERM INJECTION; JOINT CONTRACTURE; KAPLAN MEIER METHOD; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MULTIPARA; MULTIVARIATE ANALYSIS; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; OUTCOME ASSESSMENT; PARITY; PREIMPLANTATION GENETIC DIAGNOSIS; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REPRODUCTION; RESPIRATORY DISTRESS; TRINUCLEOTIDE REPEAT; GENETICS; PREGNANCY; PREGNANCY OUTCOME;

FEMALE; HUMANS; MALE; MYOTONIC DYSTROPHY; PREGNANCY; PREGNANCY OUTCOME; PREIMPLANTATION DIAGNOSIS; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EID: 77956464270     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-010-9392-9     Document Type: Article

References (33)

1. Brook JD, McCurragh ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of the trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992;69:385.
2. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253-5.
3. Harper PS, Harley HG, Reardon W, Shaw DJ. Review article: anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet. 1992;51:10-6.
4. Cho DH, Tapscott SJ. Myotonic dystrophy: emerging mechanisme for DM1 and DM2. Review. Biochim BiophysActa. 2007;1772:195-204.
5. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005;32:1-18.
6. Gennarelli M, Novelli G, Bassi A, et al. Prediction of myotonic dystrophy clinical severity based on the number of intragenic (CTG) trinucleotide repeats. Am J Med Genet. 1996;65:342-7.
7. Harper P. Myotonic dystrophy and other autosomal muscular dystrophies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. p. 4227-53.
8. Verpoest W, De Rademaeker M, Sermon K, et al. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod. 2008;23:1654-60.
9. Sermon K, Lissens W, Joris H, et al. Clinical application of preimplantation diagnosis for myotonic dystrophy. Prenat Diagn. 1997;17:925-32.
10. Sermon K, De Vos A, Van De Velde H, et al. Fluorescent PCR and automated fragment analysis for the clinical application of preimplantation genetic diagnosis (Steinert's disease). Mol Hum Reprod. 1998;4:791-6.
11. Warner JP, Barron LH, Goudie D, et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet. 1996;33:1022-6.
12. Sermon K, Seneca S, De RyckeM, Goossens V, et al. PGD in the lab for triplet repeat diseases-myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol. 2001;183: S77-8.
13. Van de Velde H, De Vos A, Joris H, Nagy ZP, Van Steirteghem AC. Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998;13:3160-4.
14. Kolibianakis EM, Zikopoulos K, Verpoest W, et al. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Hum Reprod. 2004;19:2550-4.
15. Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A. Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril. 2005;83:1397-403.
16. Liebaers I, Sermon K, Staessen C, et al. Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. Hum Reprod. 1998;13 suppl 1:186-95.
17. Bonduelle M, Liebaers I, Deketelaere V, et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod. 2002;17:671-94.
18. Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technology; World Health Organization. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod. 2009;24:2683-7.
19. Hull MG. Infertility treatment: relative effectiveness of conventional and assisted conception methods. Hum Reprod. 1992;7:785-96.
20. Osmanogaoglu K, Tournaye H, Camus M, Vandervorst M, Van Steirteghem A, Devroey P. Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow up of 498 patients. Hum Reprod. 1999;14:2651-5.
21. White RJ. Case report. Anaesthetic management of a patient with myotonic dystrophy. Paed Anaesth. 2001;11:494-7.
22. White RJ, Bass SP. Review article. Myotonic dystrophy and paediatric anaesthesia. Paed Anaesth. 2003;13:94-102.
23. Sagel J, Distiller LA, Morley JE, Isaacs H, Kay G, Van Der Walt A. Myotonia dystrophica: studies on gonadal function using luteinizing hormone-releasing hormone (LRH). J Clin Endocrinol Metab. 1975;40:1110-3.
24. Feyereisen E, Amar A, Kerbrat V, et al. Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum Reprod. 2006;21:175-82.
25. Sahu B, Ozturk O, Deo N, Fordham K, Ranierri M, Serhal P. Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I. J Assist Reprod Genet. 2008;25:1-5.
26. Winchester CL, Ferrier RK, Sermoni A, Clark BJ, Johnson KJ. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet. 1999;8:481-92.
27. O'Cochlain DF, Perez-Terzic C, Reyes S, et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004;13:2505-18.
28. Amack JD, Mahadevan MS. Myogenic defects in myotonic dystrophy. Dev Biol. 2004;265:294-301.
29. Sarkar PS, Paul S, Han J, Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet. 2004;13:1421-31.
30. Martorell L, Monckton DG, Gamez J, Baiget M. Complex patterns of male germline instability and somatic mosaicism in myotonic dystrophy type 1. Eur J Hum Genet. 2000;8:423-30.
31. Thornton CA, Johnson KJ, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994;31:518-20.
32. Monckton DG, Wong L-JC, Ashizawa T, Caskey CT. Somatic mosaicsim, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet. 1995;4:1-8.
33. Osmanogaoglu K, Tournaye H, Kolibianakis E, Camus M, Van Steirteghem A, Devroey P. Cumulative delivery rates after ICSI in women aged >37 years. Hum Reprod. 2002;17:940-4.